Literature DB >> 23985877

Apparent treatment-resistant hypertension among elderly Korean hypertensives: an insight from the HIT registry.

S-W Choi1, M-K Kim1, S W Han2, S H Han3, B K Lee4, S U Lee5, S-H Hur6, S W Lim7, K W Moon8, S G Lee9, S H Lee10, S K Oh11, J G Chea12, S J Joo13, M C Jo14, K-S Hong15, K-H Ryu1.   

Abstract

The aim of this study was to determine the clinical characteristics of patients with resistant hypertension (RH) and predictors among elderly Korean hypertensives. This prospective, multi-center, observational study evaluated 2439 elderly hypertensive patients between December 2008 and November 2011, who visited secondary hypertension clinics for high blood pressure (BP). Patients were categorized as resistant if their BP was ≥140/90 mm Hg and if they reported using antihypertensive medications from three different drug classes, including a diuretic or drugs from ≥4 antihypertensive drug classes, regardless of BP. Characteristics of patients with RH were compared with those of patients who were controlled with one or two antihypertensive medications after 6-month antihypertensive treatment. In comparison with 837 patients with non-RH, 404 patients with RH were more likely to be aware of their status of high BP before enrollment and have a high baseline systolic BP ≥160 mm Hg, microalbuminuria, high body mass index (BMI) ≥24 kg m(-2) and diabetes mellitus (DM). In drug-naive patients, awareness of hypertension at baseline was the only independent predictor for RH. In elderly Korean hypertensives, BMI (≥24 kg m(-2)), baseline systolic BP (≥160 mm Hg), microalbuminuria, DM and awareness of hypertension showed an association with RH.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23985877     DOI: 10.1038/jhh.2013.76

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  20 in total

1.  Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation.

Authors: 
Journal:  Blood Press Monit       Date:  1998-08       Impact factor: 1.444

Review 2.  Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.

Authors:  Fabio de Souza; Elizabeth Silaid Muxfeldt; Gil Fernando Salles
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-06

3.  Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk.

Authors:  Ajay K Gupta; Efthimia G Nasothimiou; Choon L Chang; Peter S Sever; Bjorn Dahlöf; Neil R Poulter
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

4.  Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring.

Authors:  Alejandro de la Sierra; Julián Segura; José R Banegas; Manuel Gorostidi; Juan J de la Cruz; Pedro Armario; Anna Oliveras; Luis M Ruilope
Journal:  Hypertension       Date:  2011-03-28       Impact factor: 10.190

5.  Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.

Authors:  Gil F Salles; Claudia R L Cardoso; Vinicius S Pereira; Roberto Fiszman; Elizabeth S Muxfeldt
Journal:  J Hypertens       Date:  2011-10       Impact factor: 4.844

6.  Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.

Authors:  Alejandro de la Sierra; José R Banegas; Anna Oliveras; Manuel Gorostidi; Julián Segura; Juan J de la Cruz; Pedro Armario; Luis M Ruilope
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

7.  Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Circulation       Date:  2005-02-08       Impact factor: 29.690

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  New semiquantitative dipstick test for microalbuminuria.

Authors:  H J Bangstad; K Try; K Dahl-Jørgensen; K F Hanssen
Journal:  Diabetes Care       Date:  1991-11       Impact factor: 19.112

Review 10.  State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.

Authors:  Pantelis A Sarafidis; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

View more
  2 in total

1.  Apparent treatment-resistant hypertension among ambulatory hypertensive patients: a cross-sectional study from 13 general hospitals.

Authors:  Sehun Kim; Jin Joo Park; Mi-Seung Shin; Choong Hwan Kwak; Bong-Ryeol Lee; Sung-Ji Park; Hae-Young Lee; Sang-Hyun Kim; Seok-Min Kang; Byung-Su Yoo; Joong-Wha Chung; Si Wan Choi; Sang-Ho Jo; Jinho Shin; Dong-Ju Choi
Journal:  Korean J Intern Med       Date:  2021-06-07       Impact factor: 2.884

2.  Kidney Function Decline and Apparent Treatment-Resistant Hypertension in the Elderly.

Authors:  Jean Kaboré; Marie Metzger; Catherine Helmer; Claudine Berr; Christophe Tzourio; Ziad A Massy; Bénédicte Stengel
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.